These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21414507)

  • 1. Use of etanercept in treating pruritus and preventing new lesions in Grover disease.
    Norman R; Chau V
    J Am Acad Dermatol; 2011 Apr; 64(4):796-8. PubMed ID: 21414507
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept in the treatment of a patient with acute generalized exanthematous pustulosis/toxic epidermal necrolysis: definition of a new model based on translational research.
    Sadighha A
    Int J Dermatol; 2009 Aug; 48(8):913-4. PubMed ID: 19659879
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of recalcitrant, erythroderma-associated pruritus with etanercept.
    Querfeld C; Guitart J; Kuzel TM; Rosen S
    Arch Dermatol; 2004 Dec; 140(12):1539-40. PubMed ID: 15611443
    [No Abstract]   [Full Text] [Related]  

  • 4. Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis.
    Gottlieb A; Feng J; Harrison DJ; Globe D
    J Am Acad Dermatol; 2010 Oct; 63(4):580-6. PubMed ID: 20599294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
    Yamauchi PS; Lowe NJ; Gindi V
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323
    [No Abstract]   [Full Text] [Related]  

  • 7. Bell's palsy during etanercept treatment caused by neuroborreliosis.
    Molin S; Ruzicka T; Prinz JC
    Br J Dermatol; 2010 Jul; 163(1):228-30. PubMed ID: 20408829
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of mucocutaneous Behçet's disease responding to etanercept.
    Sommer A; Altmeyer P; Kreuter A
    J Am Acad Dermatol; 2005 Apr; 52(4):717-9. PubMed ID: 15793540
    [No Abstract]   [Full Text] [Related]  

  • 9. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
    Yamauchi PS; Lowe NJ
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
    [No Abstract]   [Full Text] [Related]  

  • 10. Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept.
    Cusano F; Iannazzone SS; Riccio G; Piccirillo F
    Eur J Dermatol; 2010; 20(4):520. PubMed ID: 20403800
    [No Abstract]   [Full Text] [Related]  

  • 11. Ability to develop rhus allergic contact dermatitis in a patient with psoriasis receiving etanercept.
    Myers W; Newman M; Katz B; Gottlieb AB
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S127-8. PubMed ID: 17052536
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.
    D'Angelo S; Cutro MS; Lubrano E; Leccese P; Mennillo GA; Ferrara N; Olivieri I
    Ann Rheum Dis; 2010 May; 69(5):934-5. PubMed ID: 19666936
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etanercept (Enbrel)--our experiences].
    Morović-Vergles J; Martinović-Kaliterna D
    Reumatizam; 2007; 54(2):69-70. PubMed ID: 18351144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.
    Zeichner JA; Stern DW; Lebwohl M
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S120-1. PubMed ID: 16488322
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept for chronic progressive cutaneous sarcoidosis.
    Tuchinda C; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):538-40. PubMed ID: 16774106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adolescent plaque psoriasis: our experience using etanercept.
    Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.
    Prey S; Robert PY; Drouet M; Sparsa A; Roux C; Bonnetblanc JM; Bédane C
    Acta Derm Venereol; 2007; 87(1):74-5. PubMed ID: 17225020
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept is minimally effective in 2 children with atopic dermatitis.
    Buka RL; Resh B; Roberts B; Cunningham BB; Friedlander S
    J Am Acad Dermatol; 2005 Aug; 53(2):358-9. PubMed ID: 16021144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.